Elo Mutual Pension Insurance Co Cuts Stock Position in UnitedHealth Group Incorporated $UNH

Elo Mutual Pension Insurance Co reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 118,443 shares of the healthcare conglomerate’s stock after selling 1,044 shares during the quarter. UnitedHealth Group comprises approximately 0.8% of Elo Mutual Pension Insurance Co’s holdings, making the stock its 22nd largest position. Elo Mutual Pension Insurance Co’s holdings in UnitedHealth Group were worth $36,951,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Verity & Verity LLC lifted its holdings in UnitedHealth Group by 16.6% during the 2nd quarter. Verity & Verity LLC now owns 2,576 shares of the healthcare conglomerate’s stock worth $804,000 after buying an additional 367 shares in the last quarter. Laurel Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 25,471.4% in the second quarter. Laurel Wealth Advisors LLC now owns 109,190 shares of the healthcare conglomerate’s stock valued at $34,064,000 after acquiring an additional 108,763 shares in the last quarter. XTX Topco Ltd acquired a new position in UnitedHealth Group during the 2nd quarter worth $2,993,000. South Plains Financial Inc. raised its position in UnitedHealth Group by 4.0% in the 2nd quarter. South Plains Financial Inc. now owns 2,411 shares of the healthcare conglomerate’s stock valued at $752,000 after purchasing an additional 92 shares in the last quarter. Finally, Insigneo Advisory Services LLC grew its position in shares of UnitedHealth Group by 35.9% during the second quarter. Insigneo Advisory Services LLC now owns 8,037 shares of the healthcare conglomerate’s stock worth $2,507,000 after buying an additional 2,124 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.3%

UNH opened at $318.89 on Tuesday. The firm has a market cap of $288.86 billion, a price-to-earnings ratio of 16.64, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $622.83. The business’s 50 day moving average is $344.10 and its two-hundred day moving average is $315.39. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the company posted $7.15 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Analysts Set New Price Targets

Several research analysts have commented on UNH shares. UBS Group boosted their price target on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Sanford C. Bernstein boosted their target price on shares of UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Jefferies Financial Group lifted their price target on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a report on Friday, October 17th. Mizuho raised their target price on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Finally, JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.